Replies to post #13128 on Moderna Inc (MRNA)

[axelvento]

the Keynote-942/mRNA-4157-P201 study was the first demonstration of efficacy for an investigational mRNA cancer treatment in a randomized clinical trial and the first combination therapy to show a significant benefit over Keytruda alone in adjuvant melanoma!